• < 1 minute read

MBHB Partner Kevin Noonan Quoted in Benzinga Article Entitled, “Merck’s Idenix Deal Could Deliver Bad News For Gilead Sciences”

  • June 16, 2014

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in a June 16, 2014 Benzinga.com article entitled, “Merck’s Idenix Deal Could Deliver Bad News For Gilead Sciences.”  View the article

Practices & Technologies

Opinions & Counseling Litigation & Appeals Patent Portfolio Management Patent Prosecution Biotechnology & Pharmaceuticals Medical Device & Diagnostics
Facebook-f Youtube Linkedin-in
Search
Menu
People
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Services
Practices Technologies
Intelligence
NewsEventsSnippetsPatently-O BlogPatent Docs
Firm
Diversity & InclusionCommunityAwards & AccoladesOur Clients
Careers
Culture and Development Career Paths Diversity, Equity And Inclusion Legal Professionals Business Professionals
LocationContact Us
Menu